0001246360-15-001571.txt : 20150319 0001246360-15-001571.hdr.sgml : 20150319 20150319165608 ACCESSION NUMBER: 0001246360-15-001571 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150317 FILED AS OF DATE: 20150319 DATE AS OF CHANGE: 20150319 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NxStage Medical, Inc. CENTRAL INDEX KEY: 0001333170 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043454702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 MERRIMACK STREET CITY: LAWRENCE STATE: MA ZIP: 01843 BUSINESS PHONE: 978-687-4700 MAIL ADDRESS: STREET 1: 350 MERRIMACK STREET CITY: LAWRENCE STATE: MA ZIP: 01843 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burbank Jeffrey H CENTRAL INDEX KEY: 0001341411 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51567 FILM NUMBER: 15713415 MAIL ADDRESS: STREET 1: NXSTAGE MEDICAL INC STREET 2: 439 SOUTH UNION STREET 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 4 1 form.xml PRIMARY DOCUMENT X0306 4 2015-03-17 false 0001333170 NxStage Medical, Inc. NXTM 0001341411 Burbank Jeffrey H 350 MERRIMACK STREET LAWRENCE MA 01843 true true false false Chief Executive Officer Common Stock 2015-03-17 4 M false 10000 2.11 A 886756 D Common Stock 2015-03-17 4 S false 10000 17.36 D 876756 D Common Stock 2015-03-18 4 M false 10000 2.11 A 886756 D Common Stock 2015-03-18 4 S false 10000 17.43 D 876756 D Stock Option (Right to Buy) 2.11 2015-03-17 4 M false 10000 0 D 2009-04-05 2016-03-04 Common Stock 10000 179274 D Stock Option (Right to Buy) 2.11 2015-03-18 4 M false 10000 0 D 2009-04-05 2016-03-04 Common Stock 10000 169274 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2014. This represents the weighted average price for shares sold in multiple transactions at prices ranging from $16.83 to $17.48, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request. This represents the weighted average price for shares sold in multiple transactions at prices ranging from $17.29 to $17.56, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request. Aras Lapinskas, attorney-in-fact for Jeffrey Burbank 2015-03-19